Dual GLP-1/GIP receptor agonist — high concentration research vial
These products are intended for laboratory research use only and are not for human consumption. Not for use in food, drug, household, or cosmetic applications. All research should be conducted in accordance with applicable safety guidelines and regulations.
The 30mg tirzepatide vial is the highest-concentration offering for research programs requiring greater dosing capacity or extended study timelines. Its dual incretin receptor mechanism continues to be a leading subject in contemporary metabolic peptide research.
High-dose tirzepatide research has characterized the compound's tolerability profile and pharmacodynamic ceiling effects, informing understanding of GLP-1/GIP co-agonism at the receptor level.
Price comparison based on publicly available data. Competitor prices may vary.
Store in refrigerator at 4°C, tightly sealed, away from heat, light and moisture.. Keep frozen until ready to reconstitute.
Use sterile water for injection. Allow to reach room temperature before reconstitution.
Stable for 24 months when stored properly. Once reconstituted, use within 30 days.